J. Verhoef

28.4k total citations · 2 hit papers
508 papers, 22.2k citations indexed

About

J. Verhoef is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, J. Verhoef has authored 508 papers receiving a total of 22.2k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Infectious Diseases, 126 papers in Epidemiology and 120 papers in Immunology. Recurrent topics in J. Verhoef's work include Antimicrobial Resistance in Staphylococcus (116 papers), Antibiotic Resistance in Bacteria (100 papers) and Bacterial Identification and Susceptibility Testing (61 papers). J. Verhoef is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (116 papers), Antibiotic Resistance in Bacteria (100 papers) and Bacterial Identification and Susceptibility Testing (61 papers). J. Verhoef collaborates with scholars based in Netherlands, Germany and United States. J. Verhoef's co-authors include Ad C. Fluit, Sylvain Brisse, Jos A. G. van Strijp, Phillip K. Peterson, Franz‐Josef Schmitz, Henri A. Verbrugh, Paul G. Quie, Laure Diancourt, Virginie Passet and Patrick A. D. Grimont and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

J. Verhoef

504 papers receiving 20.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates

2005 1.1k citations J. Verhoef et al. profile →
Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

1990 428 citations J. F. P. Schellekens, J. Verhoef et al. The Journal of Infectious Diseases profile →

Peers

Countries citing papers authored by J. Verhoef

Since Specialization

Citations

This map shows the geographic impact of J. Verhoef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Verhoef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Verhoef more than expected).

Fields of papers citing papers by J. Verhoef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Verhoef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Verhoef. The network helps show where J. Verhoef may publish in the future.

Co-authorship network of co-authors of J. Verhoef

This figure shows the co-authorship network connecting the top 25 collaborators of J. Verhoef. A scholar is included among the top collaborators of J. Verhoef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Verhoef. J. Verhoef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibiotic Rotation and Development of Gram-Negative Antibiotic Resistance 2004 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Menno R. Vriens, Ad C. Fluit, Annet Troelstra, Christiaan van der Werken, J. Verhoef, Marc J. M. Bonten	75
2	Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992?1996 2004 ·European Journal of Clinical Microbiology & Infectious Diseases ·Bart J. M. Vlaminckx, Wilfrid van Pelt, Leo M. Schouls, A. van Silfhout, (unknown), Ellen M. Mascini, J. Verhoef, J. F. P. Schellekens	39
3	Tropical diseases : from molecule to bedside 2003 ·Kluwer Academic eBooks ·Sangkot Marzuki, J. Verhoef, H. Snippe	4
4	Multidrug Resistance among Enterobacteriaceae Is Strongly Associated with the Presence of Integrons and Is Independent of Species or Isolate Origin 2003 ·The Journal of Infectious Diseases ·Maurine A. Leverstein‐van Hall, Hetty E. M. Blok, A. Rogier T. Donders, Armand Paauw, Ad C. Fluit, J. Verhoef	221
5	Lipoprotein metabolism in patients with severe sepsis 2003 ·Critical Care Medicine ·Henk J. van Leeuwen, (unknown), Geesje M. Dallinga‐Thie, Jos A. G. van Strijp, J. Verhoef, Kok P. M. van Kessel	284
6	Activation of Human Macrophages by Amyloid-β Is Attenuated by Astrocytes 2001 ·The Journal of Immunology ·(unknown), Astrid J. van Beelen, Nanda Vos, (unknown), Tjomme van der Bruggen, J. Verhoef, F. L. Van Muiswinkel, Hans S.L.M. Nottet	40
7	[Methicillin-resistant Staphylococcus aureus in medical and paramedical personnel returned from work in a foreign hospital]. 2000 ·PubMed ·Menno R. Vriens, Annet Troelstra, Ed P. F. Yzerman, (unknown), J. Verhoef, Chr. van der Werken	4
8	Cloning and characterization of an accessory gene regulator (agr)-like locus fromStaphylococcus epidermidis 1998 ·FEMS Microbiology Letters ·Willem J. B. van Wamel, (unknown), J. Verhoef, Christina M. J. E. Vandenbroucke‐Grauls, Ad C. Fluit	46
9	Moraxella catarrhalis in Acute Laryngitis: Infection or Colonization? 1996 ·The Journal of Infectious Diseases ·(unknown), Claës Schalén, (unknown), (unknown), J. Verhoef, A. Fleer, Johannes van Dijk	13
10	Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice 1994 ·FEMS Immunology & Medical Microbiology ·(unknown), (unknown), Cees Hol, Hester J. Bootsma, J. Verhoef, Johannes van Dijk	10
11	Toxins A and B ofClostridium difficile 1994 ·FEMS Microbiology Reviews ·M. J. H. M. Wolfhagen, Ruurd Torensma, Ad C. Fluit, J. Verhoef	6
12	Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children. 1994 ·Gut ·M. J. H. M. Wolfhagen, (unknown), Ad C. Fluit, Ruurd Torensma, (unknown), A. Fleer, J. Verhoef	17
13	Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. 1992 ·Journal of Clinical Investigation ·Phillip K. Peterson, Genya Gekker, C C Chao, S X Hu, Charlene K. Edelman, H H Balfour, J. Verhoef	63
14	Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital 1992 ·RePub (Erasmus University Rotterdam) ·H. M. E. Frénay, Christina M. J. E. Vandenbroucke‐Grauls, M.J.C.H. Molkenboer, J. Verhoef	2
15	Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes 1992 ·AIDS ·Leendert J. Bakker, Hans S.L.M. Nottet, Nanda Vos, Loek de Graaf, Jos A. G. van Strijp, Maarten R. Visser, J. Verhoef	27
16	Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis 1992 ·Kidney International ·Carola W.H. de Fijter, H.A. Verbrugh, Liem P. Oe, Edith Peters, Jan van der Meulen, A. J. M. Donker, J. Verhoef	45
17	Analysis ofEscherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping 1991 ·European Journal of Clinical Microbiology & Infectious Diseases ·Carin M. A. Rademaker, (unknown), Wouter Jansen, Nanda Vos, I. M. Hoepelman, M. Rozenberg-Arska, J. Verhoef	6
18	Antibody-coated target cell membrane-induced chemiluminescence by human polymorphonuclear leukocytes 1989 ·Journal of Immunological Methods ·Kok P. M. van Kessel, Jos A. G. van Strijp, (unknown), (unknown), Ad C. Fluit, J. Verhoef	4
19	Infections in the immunocompromised host : pathogenesis, prevention, and therapy : proceedings of the First International Symposium on Infections in the Immunocomprised Host held in Veldhoven, The Netherlands, 1-5 June, 1980 1980 ·Elsevier eBooks ·J. Verhoef, Phillip K. Peterson, Paul G. Quie	1
20	Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2. 1979 ·PubMed ·Henri A. Verbrugh, Willemien C. van Dijk, R. Peters, (unknown), Phillip K. Peterson, J. Verhoef	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact